Acorda
is a New York-based biotechnology company that researches and develops neurology therapies for the treatment of Parkinson disease, migraine and multiple sclerosis... Read moreAcorda
is a New York-based biotechnology company that researches and develops neurology therapies for the treatment of Parkinson disease, migraine and multiple sclerosis... Read more
News
Aug 23, 2024
Pharamceutical Technology
Acorda: Acorda Therapeutics gets grant for sustained release 4-aminopyridine tablets for neurological disorders
Aug 09, 2024
MarketScreener
Acorda: Acorda Therapeutics : UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT OF NEW YORK Form 8 K
Jul 18, 2024
Crain's Newyork Business
Acorda: At a Glance: July 18
Jul 15, 2024
OINDPnews
Acorda: Merz Therapeutics acquires Inbrija levodopa DPI from Acorda
Jul 11, 2024
Pharamceutical Technology
Acorda: Merz wins $185m bid for bankrupt Acorda assets and increases US workforce by 50%
Jul 11, 2024
The Business Journals: Raleigh/Durham
Acorda: Raleigh firm buys bankrupt company's assets for $185 million
Jul 10, 2024
FinanzNachrichten
Acorda: Merz Therapeutics Closes $185M Asset Purchase Agreement with Acorda Therapeutics
May 15, 2024
Global Legal Chronicle
Acorda: Merz Therapeutics' $185m Acquisition of Acorda Therapeutics
May 14, 2024
Yahoo
Acorda: Acorda: Q1 Earnings Snapshot
May 14, 2024
Owler
Acorda Therapeutics, Inc.: Acorda's revenue changed from $117.63M in Dec 2023 to $115.66M in Mar 2024
Acorda Competitors
1
2
3
4
5
6
7
8
9
10